Free Trial

Grupo Mexico (OTCMKTS:GMBXF) Sets New 52-Week High - Here's What Happened

Grupo Mexico logo with Multi-Sector Conglomerates background

Grupo Mexico, S.A.B. de C.V. (OTCMKTS:GMBXF - Get Free Report)'s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $6.25 and last traded at $6.25, with a volume of 2533 shares. The stock had previously closed at $6.12.

Analysts Set New Price Targets

Separately, Morgan Stanley raised shares of Grupo Mexico to an "overweight" rating in a report on Tuesday, July 15th.

Get Our Latest Stock Report on GMBXF

Grupo Mexico Price Performance

The firm's fifty day moving average price is $5.79 and its two-hundred day moving average price is $5.31.

About Grupo Mexico

(Get Free Report)

Grupo México, SAB. de C.V. engages in copper production, cargo transportation, and infrastructure businesses worldwide. The company operates through Mining, Transportation, and Infrastructure divisions. The Mining division explores for copper, silver, molybdenum, zinc, sulfuric acid, gold, and selenium.

See Also

Should You Invest $1,000 in Grupo Mexico Right Now?

Before you consider Grupo Mexico, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grupo Mexico wasn't on the list.

While Grupo Mexico currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines